What Analyst Projections for Key Metrics Reveal About Aflac (AFL) Q3 Earnings
The upcoming report from Aflac (AFL) is expected to reveal quarterly earnings of $1.80 per share, indicating a decline of 16.7% compared to the year-ago period. Analysts forecast revenues of $4.49 billion, representing an increase of 52.2% year over year.Over the past 30 days, the consensus EPS estimate for the quarter has been adjusted upward by 1.1% to its current level. This demonstrates the covering analysts' collective reassessment of their initial projections during this period.Before a company reveals its earnings, it is vital to take into account any changes in earnings projections. These revisions play a pivotal role in predicting the possible reactions of investors toward the stock. Multiple empirical studies have consistently shown a strong association between trends in earnings estimates and the short-term price movements of a stock.While investors typically use consensus earnings and revenue estimates as indicators of quarterly business performance, exploring analysts' projections for specific key metrics can offer valuable insights.In light of this perspective, let's dive into the average estimates of certain Aflac metrics that are commonly tracked and forecasted by Wall Street analysts.According to the collective judgment of analysts, 'Revenues- Other income (loss)' should come in at $29.20 million. The estimate points to a change of +27% from the year-ago quarter.Analysts predict that the 'Revenues- Net investment income' will reach $983.85 million. The estimate indicates a year-over-year change of -2.2%.The consensus among analysts is that 'Revenues- Total net earned premiums' will reach $3.41 billion. The estimate points to a change of +2.4% from the year-ago quarter.Analysts forecast 'Total adjusted revenues- Corporate and other' to reach $336.50 million. The estimate indicates a change of +49.6% from the prior-year quarter.Analysts' assessment points toward 'Total adjusted revenues- Aflac Japan' reaching $2.43 billion. The estimate indicates a change of +2.1% from the prior-year quarter.It is projected by analysts that the 'Total adjusted revenues- Aflac Japan- Total net earned premiums' will reach $1.73 billion. The estimate suggests a change of +1.3% year over year.Analysts expect 'Total adjusted revenues- Aflac Japan- Net investment income' to come in at $698.88 million. The estimate points to a change of +4.6% from the year-ago quarter.The consensus estimate for 'Total adjusted revenues- Aflac U.S.- Other income' stands at $16.33 million. The estimate points to a change of +8.9% from the year-ago quarter.Based on the collective assessment of analysts, 'Total Benefit /Premium - Aflac Japan' should arrive at 64.7%. Compared to the current estimate, the company reported 41.8% in the same quarter of the previous year.The average prediction of analysts places 'Total Adjusted Expenses/Total Adjusted Revenue - Aflac U.S.' at 38.8%. The estimate compares to the year-ago value of 38.0%.The collective assessment of analysts points to an estimated 'Total Benefit /Premium - Aflac U.S.' of 47.8%. The estimate is in contrast to the year-ago figure of 47.6%.The combined assessment of analysts suggests that 'Total Adjusted Expenses/Total Adjusted Revenue - Aflac Japan' will likely reach 20.3%. The estimate is in contrast to the year-ago figure of 20.0%. View all Key Company Metrics for Aflac here>>> Over the past month, Aflac shares have recorded returns of -4.6% versus the Zacks S&P 500 composite's +3.6% change. Based on its Zacks Rank #3 (Hold), AFL will likely exhibit a performance that aligns with the overall market in the upcoming period. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .Zacks' Research Chief Picks Stock Most Likely to "At Least Double"Our experts have revealed their Top 5 recommendations with money-doubling potential – and Director of Research Sheraz Mian believes one is superior to the others. Of course, all our picks aren’t winners but this one could far surpass earlier recommendations like Hims & Hers Health, which shot up +209%.See Our Top Stock to Double (Plus 4 Runners Up) >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Aflac Incorporated (AFL): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks
Übrigens: Aflac und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!
Ausgewählte Hebelprodukte auf Aflac
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Aflac
Der Hebel muss zwischen 2 und 20 liegen
| Name | Hebel | KO | Emittent |
|---|
| Name | Hebel | KO | Emittent |
|---|
Quelle: Zacks
Nachrichten zu Aflac Inc
Analysen zu Aflac Inc
| Datum | Rating | Analyst | |
|---|---|---|---|
| 21.03.2018 | Aflac Equal Weight | Barclays Capital | |
| 03.07.2017 | Aflac Equal Weight | Barclays Capital | |
| 01.05.2017 | Aflac Underperform | RBC Capital Markets | |
| 02.02.2017 | Aflac Underperform | RBC Capital Markets | |
| 09.12.2016 | Aflac Underperform | RBC Capital Markets |
| Datum | Rating | Analyst | |
|---|---|---|---|
| 16.05.2012 | Aflac outperform | RBC Capital Markets | |
| 14.05.2012 | Aflac overweight | Barclays Capital | |
| 27.04.2012 | Aflac sector outperform | Scotia Capital Markets | |
| 26.04.2012 | Aflac outperform | RBC Capital Markets | |
| 27.03.2012 | Aflac overweight | Barclays Capital |
| Datum | Rating | Analyst | |
|---|---|---|---|
| 21.03.2018 | Aflac Equal Weight | Barclays Capital | |
| 03.07.2017 | Aflac Equal Weight | Barclays Capital | |
| 10.05.2016 | Aflac Mkt Perform | FBR Capital | |
| 27.04.2016 | Aflac Neutral | UBS AG | |
| 27.04.2016 | Aflac Sector Perform | RBC Capital Markets |
| Datum | Rating | Analyst | |
|---|---|---|---|
| 01.05.2017 | Aflac Underperform | RBC Capital Markets | |
| 02.02.2017 | Aflac Underperform | RBC Capital Markets | |
| 09.12.2016 | Aflac Underperform | RBC Capital Markets | |
| 09.01.2012 | Aflac sell | UBS AG |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Aflac Inc nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen